The Economist looks into how companies are trying to harness the gut microbiome to influence health and disease.
A pair of papers point to potential gut microbial contributions to checkpoint blockade immunotherapy response in individuals with lung, kidney, or skin cancer.
Researchers crowdsourced thousands of microbiome samples to examine global microbial diversity and generate a resource for researchers.
Researchers found microbial communities at sites of the female reproductive tract thought to be sterile, and linked certain microbes to disease states.
People with atherosclerotic cardiovascular disease have increased levels of certain bacteria in their stool, a metagenome-wide association study has found.
In PLOS this week: nasopharyngeal microbiota among young children, splice variant linked to oculocutaneous albinism in a dog breed, and more.
The team tested 21 protocols for extracting DNA from human fecal microbiome samples to recommend one to improve comparability between studies.
Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.
Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.
Additional Human Microbiome Project samples have enabled a deeper look into the stability and molecular processes of the microbes that live on and in people.
The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.
According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.
New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.
In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.